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ABSTRACT  
Mouth dissolving film is the most advanced oral solid dosage form due to its flexibility and comfort in use. Mouth dissolving films are oral solid 
dosage form that disintegrate and dissolve within a minute when placed in mouth without taking water or chewing. This dosage form allows 
the medication to bypass the first pass metabolism so bioavailability of medication may be improved .Mouth dissolving film has potential to 
improve onset of action lower the dosing and eliminate the fear of chocking. Formulation of mouth dissolving films involves both the visual and 
performance characteristics as plasticized hydrocolloids, API taste masking agents are being laminated by solvent casting and semisolid casting 
method. Solvent casting method being the most preferred method over other methods because it offers great uniformity of thickness and films 
prepared having fine glossy look and better physical properties. Mouth dissolving films are evaluated for its various parameters like thickness, 
physical property like folding endurance, disintegration and dissolution time. This review gives an idea about formulation techniques, 
evaluation parameters, overview on packaging and some available marketed products of mouth dissolving films. 
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INTRODUCTION:  
Oral route of drug administration is a most preferred route 
due to its ease of administration, non-invasiveness, 
adaptability, patient compliance and acceptability. 
Regarding oral route of drug administration, many 
substitutes have continuously been presented by using 
recent novel technologies for pediatrics, geriatrics, nauseous 
and non-compliance patients. Bioadhesive mucosal dosage 
forms including adhesive tablets, gels and patches are 
outcomes of technological development. Among various 
dosage forms, the use of polymeric films for delivering 
medication into buccal cavity has developed great potential 
in recent area. Orally disintegrating films (ODFs), when 
placed on tongue, immediately hydrates by soaking saliva 
following disintegration and/or dissolution releasing active 
pharmaceutical agent from the dosage form. ODFs are kind 
of formulations which are commonly prepared using 
hydrophilic polymers enabling rapid dissolution upon 
contact with saliva. Oral disintegrating tablets (ODTs) and 
oral disintegrating films (ODFs) are the typical examples of 
orally disintegrating drug delivery systems. These systems 
were developed in late 1970 to serve as an alternative to 
conventional dosage forms, for instance, fast disintegrating 
tablets and capsules for geriatrics and pediatric patients 
having difficulty in swallowing conventional dosage forms. A 
typical ODF is usually equal to the size of a postage stamp[1]. 
In market place, the introduction of ODT was strongly 
associated with counseling of patients about the appropriate 
administration by giving instruction like ‘‘do not chew/do 
not swallow’’. However, in spite of these instructions, 
incidents regarding chewing and swallowing were often 
reported. But, ODFs untied the masses from these adverse 
events. The administration of ODFs has numerous 
advantages and some of them are as follows: 
i. Easy transportation. 
ii. Ease of swallowing for geriatrics and pediatrics. 
iii. Convenient and accurate dosing. 
iv. No need of water for administration. 
v. Convenient for dysphasic patients having difficulty in 
swallowing tablets and   capsules. 
vi. Rapid onset of action with increased bioavailability due to 
bypassing hepatic first pass effect and stability 
No expensive lyophilization, high mechanical strength, rapid 
disintegration, and reduced choking risks are the quality 
attributes of ODFs21a have attained remarkable significance 
in pharmaceutical industry for the reason of possessing 
unique properties and fast disintegration time ranging from 
seconds to one minute ODFs design permits to incorporate a 
variety of drugs for their pharmacological effects e.g., anti-
tussive, anti-epileptic, anti-asthmatic, expectorant, etc. .High 
temperature and moisture [2]. 
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SPECIAL FEATURES OF MOUTH DISSOLVING FILMS 
1. Thin elegant film 
2. Unconstructive 
3. Available in various size and shapes 
4. Fast disintegration 
5. Rapid release 
6. Give a pleasant mouth feel. 
7. Have an acceptable taste. 
8. Should not leave residues in mouth. 
DISADVANTAGES 
1. Dose uniformity is a technical challenge. 
2. Hygroscopic in nature. 
3. High doses cannot be incorporated (<40 mg/4cm2 piece) 
4. Require special packaging for products stability and 
safety. 
 
COMPOSITION OF MOUTH DISSOLVING FILM [3]: 
     Composition Concentration 
Drug            1-25% 
Water soluble polymer 40-50% 
Plasticizers        0-20% 
Fillers, colors ,flavors 0-40% 
 
2. FORMULATION ASPECTS FOR MOUTH 
DISSOLVING FILMS: 
Active Pharmaceutical Ingredient:   
Various classes of drugs can be incorporated into ODFs e.g., 
anti-histamine, anti-diarrheal, anti-depressants, 
vasodilators, anti-asthmatic, anti-emetic, etc.  
Dimenhydrinate can also be incorporated into ODFs for taste 
masking. Common examples of drugs incorporated into 
ODFs are salbutamol sulfate, rizatriptan benzoate, verapamil 
ondansetron, dexamethasone, rofecoxib, cetirizine, 
pilocarpine, tianeptine sodium, indomethacin, etc. 
Film Forming Polymer:  
Water-soluble polymers are used as film formers as they 
provide quick disintegration, good mouth feel, and 
mechanical strength to the films. The robustness of the strip 
depends on  the type of polymer and its amount in the 
formulations. A variety of polymers are available for 
preparation of films of which pullulan, gelatin and 
hypromellose are most commonly used. Examples of water-
soluble polymers include: Pullulan, Gelatin, guar gum, 
xanthan gum, Hydroxyl propyl methyl cellulose (HPMC), 
Modified starches, PVPK30, PVA etc. HPMC E3/E5/E6/E15. 
Ideal properties of the polymers used in the oral film: 
1. Polymers should be nontoxic, non- irritant and non-bitter. 
2. Polymers should be tasteless 
3. It should be devoid of leachable impurities 
4. It should be inexpensive and readily available 
5. It should not be an obstacle in the disintegration time 
6. It should have good wetting and spreadibility property 
7. It should exhibit sufficient peel, shear and tensile strength 
8. It should not cause secondary infection in the oral cavity 
and should have sufficient shelf life.[4] 
Plastisizers:  
In general, mechanical properties such as tensile strength 
and percent elongation are improved by adding plasticizer 
to the formulations. The concentration of plasticizer usually 
ranges from 0% to 20% w/w. Common examples of 
plasticizers are PEG, glycerol, diethyl phthalate, triethyl 
citrate, tributyl citrate, etc. 
Sweetening Agent: 
Sweeteners have become an important part of the food 
products as well as pharmaceutical products intended to be 
disintegrated or dissolved in the oral cavity. Natural 
sweeteners as well as artificial sweeteners are used to 
improve the palatability of the mouth dissolving 
formulations. Some suitable sweeteners include:  
(1) Water soluble natural sweetener: xylose, ribose, glucose, 
sucrose, maltose, stevioside etc.  
(2) Water soluble artificial sweetener: sodium or calcium 
saccharin salts, acesulfame-K etc.  
(3) Dipeptide based sweetener: aspartame 
Saliva Stimulating Agent: 
Salivary stimulants are generally acidic in nature stimulating 
the production of saliva in buccal cavity, consequently, 
promoting the disintegrating of ODFs. Some commonly used 
saliva stimulating agents are citric acid, malic acid, tartaric 
acid, ascorbic acid and lactic acid. 
Surfactant: Surfactants are used as solubilizing or wetting 
or dispersing agents as a result that the film gets dissolved 
within seconds and release active agent immediately. 
Surfactants also improve the solubility of poorly soluble 
drugs in fast dissolving buccal films. E.g.: Polaxamer 407, 
sodium lauryl sulfate, benzalkonium chloride, benzthonium 
chloride, tweens and spans etc. 
Flavor: Flavors are needed to mask the bitter or nauseating 
taste of incorporated drug. Amount of flavor depends upon 
its nature and strength. Any US-FDA approved flavor can be 
used such as sweet, sour or mint flavor one of the research 
work verified that mint, licorice and sucralose mixture 
flavors appropriately mask the bitter taste of diclofenac 
sodium. Electronic tongues are used to discriminate the 
effect of various taste masking agents (TMAs) 
Colouring Agent: Pigments such as titanium dioxide or 
FD&C approved coloring agents are incorporated (not 
exceeding concentration levels of 1%w/w) in oral strips 
when some of the formulation ingredients or drugs are 
present in insoluble or suspension form[5]. 
3. METHOD OF PREPARATION OF FAST 
DISSOLVING FILM:  
One or a combination of the following processes can be used 
to manufacture the Mouth dissolving film: 
1. Solvent casting 
2. Hot-melt extrusion 
3. Semisolid casting 
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4. Solid dispersion extrusion 
5. Rolling 
1. Solvent Casting Method:  
Solvent casting is the most commonly used method for the 
preparation of ODFs using water soluble excipients, 
polymers and drug which are dissolved in de-ionized water; 
consequently, a homogenous mixture is obtained by 
applying high shear forces generated by a shear processor. 
Then, the prepared solution is poured onto petri plate and 
the solvent is allowed to dry by exposing it to high 
temperature in order to attain good quality films. An 
orodispersible film of tianeptine sodium was successfully 
prepared through solvent casting technique using different 
grades of Lycoat and HPMC. In solvent casting technique, 
film forming polymer is usually soaked in an appropriate 
solvent for overnight. The type of API, which has to be 
incorporated in ODF, governs the selection of a suitable 
solvent depending on critical physico- chemical properties of 
API such as melting point, shear sensitivity and polymorphic 
form. Compatibility of drug with solvent and other 
excipients is also brought under consideration before 
finalizing a formulation. During formulation, entrapment of 
air bubbles can hinder the uniformity of prepared films. 
Thus, deaeration of the mixture is carried out with the help 
of a vacuum pump. Orodispersible film formulation of 
mosapride was also successfully prepared by using solvent 
casting method. Viscosity of the solution to be poured is an 
imperative aspect in casting method. The concentration of 
pullulan varying from 2% to 8% results into low viscosity 
solution, as a result, enabling easy casting of films. Fast 
disintegrating films of anastrozole were also effectively 
prepared with the help of solvent casting method employing 
HPMC (E5) and polyvinyl alcohol (PVA)[6,7]. 
2. Hot Melt Extrusion:  
Hot melt extrusion is a technique in which a mixture 
containing drug, polymer and excipients is extruded under 
high temperature to form a homogenous mass which is then 
coasted to form smooth films. This is a solvent free process; 
however, the processing of thermolabile substances is a 
major drawback of this process due to the use of high 





Semi Solid Casting Method:  
This method is preferably adopted when acid insoluble 
polymers are to be used in the preparation of the films. Acid 
insoluble polymers used to prepare films include: cellulose 
acetate phthalate, cellulose acetate butyrate. Acid insoluble 
polymer and film forming polymer should be used in the 
ratio of 1:4. 
 
Solution of water soluble film forming polymer is prepared 
 
Resulting solution is added to a solution of acid insoluble polymer 
 
Appropriate amount of plasticizer is added so that gels mass is obtained 
 
Finally the gel mass is casted in to the film or ribbons using heat controlled drums 
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Solid Dispersion Extrusion Method:  
Solid dispersion of domperidone using beta-cyclodextrin, 
PEG400 and HPMC E15 was successfully prepared and 




Rolling Method [11, 12]: 
Plot of rolling method is prepared solution should possess 
specific rheological properties for rolling onto the drum. 
Preparation of suspension of drug and polymer in water or 
alcohol Suspension is subjected to rollers   Suspension is 
subjected to rollers Evaporation of solvent Evaporation of 
solvent                 
4. EVALUATION PARAMETERS: 
 Thickness test: Thickness of a film is determined by using 
calibrated digital micrometer and then subsequently mean 
average is calculated. Generally, three readings from all the 
batches are determined and average is calculated. Weight 
variation of a film is calculated in triplicate by cutting the 
film and determining weight of each film. Uniformity in 
thickness is important to as certain as it is directly 
proportional to dose accuracy of the film[13]. 
Tack test: Tack is the tenacity with which the film adheres 
to the accessory that has been pressed into contact with 
strip. This test also determines the dryness[14]. 
Tensile strength: Tensile strength is defined as maximum 
stress applied at which the film breaks. Basically, this test is 
performed to measure the mechanical strength of films. It 
can be calculated from applied load at rupture divided by the 
strip cross-sectional area given in the equation below[14, 15]: 
Tensile strength = Load at breakage/ Strip thickness × Strip 
Width 
Percentage elongation: When the sample films are 
subjected to tensile stress, deformation of the films occurs 
resulting in stretching or elongation of sample. It is 
performed to predict the ductility of polymers using a 
texture analyzer. It is calculated by formula: 
% Elongation = Increase in length ×100 / Original length 
Folding endurance: To determine folding endurance, a 
portion of film is cut and repeatedly folded at the same point 
till it breaks. The number of times the film could be folded at 
the same point without breaking indicates the folding 
endurance value. Typical folding endurance for a film ranges 
between 100- 150[16]. 
Swelling property: Simulated saliva solution is used to 
check the swelling studies of films. Initial weight of film is 
determined and is placed in pre weighed stainless steel wire 
mesh. This mesh containing film is then dipped into 
simulated saliva solution. Increase in the weight of film is 
noted at constant pre-determined time intervals until no 
more increase in weight. Degree of swelling is determined by 
these parameters: 
Degree of swelling = final weight (wt) – Initial weight (w0)/ 
Initial weight (w0) 
Wt = weight of film at time interval t, w0 =weight of film at 
time 0. 
Surface pH: The pH value of a film is usually determined by 
putting the prepared film in Petri dish and subsequently film 
is made wet by using distilled water and noting pH by 
touching the film surface with a pH meter electrode. 
Determination of surface pH is vital as acidic or basic pH is 
liable to cause oral mucosal irritation.[16,17] 
 
Content uniformity: Contents of a film are determined by 
standard assay method specified for individual drug in 
different pharmacopoeia. This test is performed on 20 
samples using analytical techniques. The acceptance value of 
the test is less than 15% in accordance with Japanese 
pharmacopoeia. According to USP27, the contents should 
range from 85% to 115% with the standard deviation of less 
than or equal to 6% Content uniformity is worked out for 
estimating drug contents in individual film[18, 19]. 
Disintegration time: Disintegration apparatus mentioned 
in official pharmacopoeias is used for determining the 
disintegration time of a film. Normally, the disintegration 
time is the function of composition of film as it varies with 
the formulation and generally ranges from 5 to 30 s. Mostly, 
the USP disintegration apparatus is used for this test. There 
are no official guidelines available for determining 
disintegration time of orally fast disintegrating films. There 
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are two methods for determining disintegration time of 
film[20]. 
Slide frame method: A drop of distilled water is poured 
onto the film clamped into slide frames placed on petri dish. 
Time taken by the film to dissolves noted[21]. 
 Petri dish method: A film is placed into 2 ml distilled water 
taken in Petri dish. Time taken by the film to dissolve 
completely is considered as the disintegrating[22]. 
In-vitro dissolution test: Standard official basket or paddle 
apparatus is used for conducting dissolution studies on 
films. Sink conditions should be maintained during 
dissolution. Sometimes while performing this process, film 
floats over the medium making it difficult to perform the test 
properly. This problem is more likely to occur in case of 
paddle method thus the basket apparatus is mostly 
preferred. Media used are 6.8 pH phosphate buffer (300 ml) 
and 0.1 N HCl (900 ml). Temperature is maintained at 37 ± 
0.5 C and rotation speed of 50 rpm is usually adjusted. 
Samples of drug dissolved are collected at pre-determined 
intervals and are analyzed by using UV-spectrophotometer. 
Despite its extensive use, dissolution test is still prone to 
noteworthy inaccuracy and tests let down [23, 24]. 
CONCLUSION:  
The present review shows that oral fast disintegrating films 
are one of the novel approaches in the field of 
pharmaceutical sciences. They have improved acceptance 
and patient compliance with no risk of choking associated 
with better safety and efficacy in comparison with 
conventional dosage forms. The main idea behind 
formulation of ODFs was to cope with the difficulty in 
swallowing conventional oral dosage forms among pediatric, 
geriatric and psychiatric patients with dysphagia.Presently, 
ODFs are widely available for hypertension, acidity, allergy, 
pain, etc. reflecting their importance. Major advantages of 
such dosage form are their administration without the use of 
water fulfilling the need of target population seeking 
convenience in drug administration along with bypassing 
the hepatic metabolism, consequently, leading to improved 
therapeutic response. 
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